Health Condition 1: null- Patients suffering from the Benign prostatic hyperplacia
Conditions
Interventions
Intervention1: Uricare Tablet: It contains Ext. Crataeva religiosa, Ext. Boerhavia diffusa, Ext. Tinospora cordifolia, Shuddha Shilajit, Commiphora mukul
Dose: 2 tablet twice a day
Route of administar
Sponsors
PETLAD MAHAL AROGYA MANDAL PHARMACY
Eligibility
Inclusion criteria
Inclusion criteria: Patients having symptoms like Difficulty starting urine stream, Weal flow of urine, Dribbling of urine, Dysuria, Feeling like bladder is not completely empty are included for the study.
Exclusion criteria
Exclusion criteria: Patients already having Hypertension, Suffering from auto immune disorder, Spastic or genetic disorder, and also on long term steroidal treatment, who is not willing to fill Informed consent form, are excluded from the trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The predefined primary end points are rapid symptomatic relief from Prostate Enlargment, Hypertention, and Urolithiasis.Timepoint: in 6 weeks of time period | — |
Secondary
| Measure | Time frame |
|---|---|
| The predefined secondary endpoints are short- and long-term safety, and overall compliance to the drug treatmentTimepoint: in entire study time and also on follow up visits | — |
Countries
India
Contacts
Public ContactDrManish Patel
P.D.Patel Ayurvedic Hospital, Nadiad
Outcome results
None listed